These Were the Top-Selling GLP-1 Drugs Last Quarter From Eli Lilly and Novo Nordisk The Motley Fool Ozempic remains on top in the GLP-1 drug market — but for how long? Eli Lilly (LLY) NYSE Science Space 3 weeks
Fake GPT-written studies are flooding Google Scholar. Here’s why taking them down could make things worse. Business Insider 5 hours
Ardagh Metal Packaging SA (AMBP): Hedge Funds Are Bullish On This US Stock to Buy Under $5 Now Insider Monkey 7 hours
Goldman Thinks Hawaiian Electric Industries, Inc. (HE) Is A Long-Term AI Stock Set To Rally Eventually Insider Monkey 7 hours
Jones Lang LaSalle Incorporated (JLL): A Very Important AI Stock According to BlackRock Insider Monkey 8 hours
Iron Mountain Incorporated (IRM): A Very Important AI Stock According to BlackRock Insider Monkey 8 hours
Billionaire Bill Ackman Wants to Buy This Entire Company – Could Its Investors Get a Big Payday? The Motley Fool 11 hours
This 5%-Yielding Passive-Income Stock Just Increased Its Dividend for the 108th Straight Quarter (and There’s Plenty More to Come) The Motley Fool 12 hours